Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare News Papua New Guinea.
November 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
December 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
January 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on December 30, 2025
December 30, 2025
SRx Health Solutions Deploys Initial $10 Million into Several Digital Assets Predominantly Bitcoin and Ethereum
Indeterminate
GlobeNewswire
December 30, 2025
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
Indeterminate
GlobeNewswire
December 30, 2025
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
Indeterminate
GlobeNewswire
December 30, 2025
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
Indeterminate
GlobeNewswire
December 30, 2025
Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors
Indeterminate
GlobeNewswire
December 30, 2025
InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire
December 30, 2025
The 2025 Brain Health Breakthrough of the Year
Indeterminate
GlobeNewswire
December 30, 2025
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
Indeterminate
GlobeNewswire
December 30, 2025
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis
Indeterminate
GlobeNewswire
December 30, 2025
Beyond Air® Appoints Dan Moorhead as Chief Financial Officer
Indeterminate
GlobeNewswire
December 30, 2025
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
Indeterminate
GlobeNewswire
December 30, 2025
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
Indeterminate
GlobeNewswire
December 30, 2025
InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum
Indeterminate
GlobeNewswire
December 30, 2025
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026
Indeterminate
GlobeNewswire
December 30, 2025
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire